Long-Term Follow-Up of Mitomycin C Nephropathy.
スポンサーリンク
概要
- 論文の詳細を見る
Two cases of mitomycin C nephropathy, which occurred after postoperative chemotherapy for advanced gastric cancer, were followed up for 6 (case 1) and 10 years (case 2). Hemolytic uremic syndrome developed 68 days (case 1) and 160 days (case 2) after the last administration of MMC with a total dose of 60 mg (case 1) and 40 mg (case 2). Serum creatinine levels were normalized in case 1 and they remained at about 2 mg/dl in case 2. Hyporeninemic hypoaldosteronism was transiently seen in case 2. These data suggest that recovery from the acute phase of hemolytic uremic syndrome leads to a good long-term prognosis in MMC nephropathy.(Internal Medicine 33:180-184, 1994)
- 社団法人 日本内科学会の論文
著者
-
Yokoyama Hitoshi
The First Department Of Internal Medicine School Of Medicine Kanazawa University
-
Takemori Yasuhiro
The Department Of Internal Medicine Toyama Rosai Hospital
-
OHTA Hideki
The Department of Internal Medicine, Cancer Research Institute, Kanazawa University
-
MOTOO Yoshiharu
the Department of Internal Medicine, Cancer Research Institute, Kanazawa University
-
OKAI Takashi
the Department of Internal Medicine, Cancer Research Institute, Kanazawa University
-
SAWABU Norio
the Department of Internal Medicine, Cancer Research Institute, Kanazawa University
-
IKEDA Kenzo
The First Department of Internal Medicine, School of Medicine, Kanazawa University
-
TAKEMORI Yasuhiro
The Department of Internal Medicine, Cancer Research Institute, Kanazawa University
関連論文
- Intestinal Obstruction in Autosomal Dominant Polycystic Kidney Disease
- Steroid Pulse Therapy in Lupus Cystitis
- Hepatic Veno-Occlusive Disease in a Case of Polymyositis Associated with Thrombotic Thrombocytopenic Purpura/hemolytic Uermic Syndrome
- Methylprednisolone Pulse Therapy in Two Clinical Types of Crescentic Glomerulonephritis
- Amyotrophic Lateral Sclerosis Associated with the Syndrome of Inappropriate Secretion of Antidiuretic Hormone.
- Long-Term Follow-Up of Mitomycin C Nephropathy.
- Rapidly Growing Mucinous Cholangiocarcinoma.
- Exacerbation of Hypothyroidism Following Tumor Necrosis Factor-.ALPHA. Infusion.